Zylö Therapeutics offers an innovative sustained-release drug-delivery system.
Zylö Therapeutics has raised $294K in total funding. The most recent round was Grant. The last funding was announced in May 2023.
Zylö Therapeutics's investors include New York Angels, VentureSouth, SC Launch, Inc., Chemical Angel Network, Harvard Business School Alumni Angels of Greater NY.
Zylö Therapeutics is headquartered in Greenville, United States.
Zylö Therapeutics offers an innovative sustained-release drug-delivery system.
Zylö Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Zylö Therapeutics — Funding & Investors." VCBacked, May 31, 2023, https://www.vcbacked.co/company/zyl-therapeutics. Accessed November 11, 2026.
VCBacked. (2023). Zylö Therapeutics — Funding & Investors. Retrieved November 11, 2026, from https://www.vcbacked.co/company/zyl-therapeutics
{{cite web |title=Zylö Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/zyl-therapeutics |website=VCBacked |access-date=November 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Zylö Therapeutics? Request a listing update